The move comes after international studies revealed that Gatifloxacin posed 17 times higher risk of developing serious hyperglycemia than other antibiotics in elderly patients.
Scientists at the Humboldt University, Berlin, have revealed that a new drug has been found extremely effective in treating nearly all symptoms associated with chronic constipation.